The combination of zolbetuximab plus chemotherapy produced one of the longest overall survival outcomes ever seen for patients with advanced caludin18.2+ gastric or gastroesophageal junction cancer.
In a large French study, bariatric surgery was associated with a significant reduction in incidence of esophageal and gastric cancer as well as overall mortality.
With the last update published in 2017, current consensus, released in August 2022, covers most of the latest progress made in the management of the infection.
Cancer mortality rates among American Indian and Alaska Native patients are higher than for White patients despite similar rates of cancer incidence overall.